Bend Bioscience has expanded its operations in Clearwater, Florida, and Gainesville, Georgia, positioning itself as a leader in next-generation contract development and manufacturing organization (CDMO) services. The company is dedicated to addressing the complexities of oral and inhaled drug delivery, leveraging advanced scientific methodologies and collaborative service models to support pharmaceutical innovators from early development stages to commercial scale-up. In an exclusive discussion with Contract Pharma, CEO Owen Murray highlighted the company’s commitment to transforming scientific breakthroughs into viable therapies, emphasizing the importance of tailored solutions that meet the unique challenges of modern drug development.
As the pharmaceutical landscape evolves, the need for CDMOs that can navigate the intricacies of drug formulation is paramount. Bend Bioscience’s strategic focus on overcoming bioavailability issues and its expertise in pediatric and geriatric modalities positions it to meet the growing demand for innovative drug delivery systems. This expansion not only enhances its operational capabilities but also reinforces its role as a critical partner for biopharmaceutical companies aiming to bring complex therapies to market efficiently and effectively.
Start your 7-day trial and see what the database can do →
